Sponsored by:

Earlier diagnostics enables faster Alzheimer's treatment

Erik Ridley Headshot
Erik L. Ridley
Jun 1, 2023
2023 06 01 22 53 4403 2023 06 02 Quest Video 400

New advances in diagnostics can help detect Alzheimer's disease sooner, enabling patients to benefit from new treatments to slow down progression, said Quest Diagnostics Medical Director for Neurology Dr. Michael Racke in a video interview.


Latest in Molecular Imaging
Isotopes1
Ratio Therapeutics inks radioisotope supply deal with Nusano
June 18, 2025
Alzheimer's Case Study
Sponsored
Alzheimer's Case Study
June 6, 2025
Ame 2018 12 11 00 02 7009 Atom Nuclear Lab 400
Ratio Therapeutics partners with Macrocyclics
June 13, 2025
2025 06 12 Visual Abstract Thumbnail
PSMA-PET/CT improves survival in men with prostate cancer
June 12, 2025
Related Stories
2023 06 25 00 42 9458 2023 06 25 Snmmi Pet Brain Tracer 20230625005536
Nuclear Medicine
PET tracer images brain cholesterol metabolism
2022 01 12 18 18 1479 Patient Elderly Confused Headache 400
Molecular Imaging
CMS to cover Alzheimer's drugs for patients enrolled in registry
2021 10 27 18 08 3227 Business Costs Rising Arrow Up 400
Molecular Imaging
Will lecanemab approval increase PET scan volumes?
Alzheimer's Case Study
Sponsor Content
Alzheimer's Case Study
More in Molecular Imaging
Ratio Therapeutics inks radioisotope supply deal with Nusano
By AuntMinnie.com staff writers
Ratio Therapeutics is developing radiopharmaceuticals for imaging and treating cancer.
June 18, 2025
Isotopes1
Study highlights clinical potential of tau PET scans
By Will Morton
A new study offers a better understanding of the potential of tau PET in Alzheimer's disease patients.
June 16, 2025
Ad
Ratio Therapeutics partners with Macrocyclics
By AuntMinnie.com staff writers
The agreement will enable access to Macropa in Japan, Canada, Australia, and a majority of Europe, according to Ratio.
June 13, 2025
Ame 2018 12 11 00 02 7009 Atom Nuclear Lab 400
PSMA-PET/CT improves survival in men with prostate cancer
By Will Morton
Researchers report that PSMA-PET/CT improves survival in men with recurrent prostate cancer treated with salvage radiotherapy.
June 12, 2025
2025 06 12 Visual Abstract Thumbnail
GE HealthCare highlights combined software with MIM Encore
By AuntMinnie.com staff writers
GE HealthCare has combined its software features and algorithms with the MIM Encore platform.
June 12, 2025
Ge Health Care Logo
MolecuLight touts published research on i:X device
By AuntMinnie.com staff writers
MolecuLight is highlighting research showing the efficacy of MolecuLight's i:X device on managing deep sternal wound infections.
June 12, 2025
Molecu Light Logo
Radiopharm secures fast-track designation for brain PET tracer
By AuntMinnie.com staff writers
Radiopharm has received fast-track designation from the U.S. Food and Drug Administration for its F-18 RAD101 PET radiotracer.
June 11, 2025
Brain Theranostics2
Positrigo closes $8.5M funding round
By AuntMinnie.com staff writers
Firm also notes board changes.
June 10, 2025
Money Pile 400
Aktis secures INDs for new theranostics pair
By AuntMinnie.com staff writers
Aktis has received investigational new drug (IND) clearance for a phase IB clinical trial of a nectin-4-targeted theranostics pair.
June 9, 2025
Breast Cancer2
PET/CT supports use of infliximab for cardiac sarcoidosis
By Will Morton
FDG-PET/CT imaging has provided new evidence that infliximab is effective for treating cardiac sarcoidosis.
June 9, 2025
Cs Pet Ct y2 A Pd6 Q Oa O Thumbnail
PET tracer for prostate cancer performs well in clinical trial
By Will Morton
A new PET tracer for detecting prostate cancer performed well in a phase II/III clinical trial.
June 9, 2025
F3large 1 xj1 Zozzq In Thumbnail
Animal studies for PET drugs begin phasing out
By Will Morton
Dosing safety studies in animals for new PET radiotracers are being phased out.
June 6, 2025
Animal Testing
Page 1 of 606
Next Page